Home/Filings/4/0000950172-05-001261

4//SEC Filing

QUESTCOR PHARMACEUTICALS INC 4

Accession 0000950172-05-001261

CIK 0000891288operating

View on SEC.gov Company Profile

Filed

Apr 18, 8:00 PM ET

Accepted

Apr 19, 5:58 PM ET

Size

21.3 KB

Accession

0000950172-05-001261

Insider Transaction Report

Form 4

Period: 2005-04-15

QUESTCOR PHARMACEUTICALS INCQSC

CAVAZZA CLAUDIO

10% Owner

Transactions

Other
Common Stock, no par value per share
2005-04-15−1,265,822→ 0 total(indirect: Shares underlying the 8% Convertible Debenture held by Defiante Farmaceutica L.d.A.)
Other
8% Convertible Debenture
2005-04-15$2000000.00/sh(indirect: The 8% Convertible Debenture was directly held by Defiante Farmaceutica L.d.A.)
Exercise: $1.58Exp: 2005-04-15→ Common Stock, no par value per share (1,265,822 underlying)

Holdings

Common Stock, no par value per share
(indirect: Shares directly held by Paolo Cavazza.)
1,756,782
Common Stock, no par value per share
(indirect: Shares directly held by Chaumiere - Consultadoria & Servicos SDC Unipessoal LDA.)
100,000
Common Stock, no par value per share
(indirect: Shares directly held by Aptafin S.p.A.)
549,100
Common Stock, no par value per share
(indirect: Shares directly held by Claudio Cavazza.)
1,756,781
Common Stock, no par value per share
(indirect: Shares directly held by Defiante Farmaceutica L.d.A.)
759,493
Common Stock, no par value per share
8,643,397

APTAFIN S P A

10% Owner

Transactions

Other
Common Stock, no par value per share
2005-04-15−1,265,822→ 0 total(indirect: Shares underlying the 8% Convertible Debenture held by Defiante Farmaceutica L.d.A.)
Other
8% Convertible Debenture
2005-04-15$2000000.00/sh(indirect: The 8% Convertible Debenture was directly held by Defiante Farmaceutica L.d.A.)
Exercise: $1.58Exp: 2005-04-15→ Common Stock, no par value per share (1,265,822 underlying)

Holdings

Common Stock, no par value per share
(indirect: Shares directly held by Chaumiere - Consultadoria & Servicos SDC Unipessoal LDA.)
100,000
Common Stock, no par value per share
8,643,397
Common Stock, no par value per share
(indirect: Shares directly held by Paolo Cavazza.)
1,756,782
Common Stock, no par value per share
(indirect: Shares directly held by Claudio Cavazza.)
1,756,781
Common Stock, no par value per share
(indirect: Shares directly held by Defiante Farmaceutica L.d.A.)
759,493
Common Stock, no par value per share
(indirect: Shares directly held by Aptafin S.p.A.)
549,100

SIGMA TAU FINANZIARIA SPA

10% Owner

Transactions

Other
8% Convertible Debenture
2005-04-15$2000000.00/sh(indirect: The 8% Convertible Debenture was directly held by Defiante Farmaceutica L.d.A.)
Exercise: $1.58Exp: 2005-04-15→ Common Stock, no par value per share (1,265,822 underlying)
Other
Common Stock, no par value per share
2005-04-15−1,265,822→ 0 total(indirect: Shares underlying the 8% Convertible Debenture held by Defiante Farmaceutica L.d.A.)

Holdings

Common Stock, no par value per share
8,643,397
Common Stock, no par value per share
(indirect: Shares directly held by Claudio Cavazza.)
1,756,781
Common Stock, no par value per share
(indirect: Shares directly held by Paolo Cavazza.)
1,756,782
Common Stock, no par value per share
(indirect: Shares directly held by Chaumiere - Consultadoria & Servicos SDC Unipessoal LDA.)
100,000
Common Stock, no par value per share
(indirect: Shares directly held by Defiante Farmaceutica L.d.A.)
759,493
Common Stock, no par value per share
(indirect: Shares directly held by Aptafin S.p.A.)
549,100

SIGMA TAU INTERNATIONAL SA

10% Owner

Transactions

Other
8% Convertible Debenture
2005-04-15$2000000.00/sh(indirect: The 8% Convertible Debenture was directly held by Defiante Farmaceutica L.d.A.)
Exercise: $1.58Exp: 2005-04-15→ Common Stock, no par value per share (1,265,822 underlying)
Other
Common Stock, no par value per share
2005-04-15−1,265,822→ 0 total(indirect: Shares underlying the 8% Convertible Debenture held by Defiante Farmaceutica L.d.A.)

Holdings

Common Stock, no par value per share
(indirect: Shares directly held by Aptafin S.p.A.)
549,100
Common Stock, no par value per share
(indirect: Shares directly held by Chaumiere - Consultadoria & Servicos SDC Unipessoal LDA.)
100,000
Common Stock, no par value per share
(indirect: Shares directly held by Claudio Cavazza.)
1,756,781
Common Stock, no par value per share
(indirect: Shares directly held by Paolo Cavazza.)
1,756,782
Common Stock, no par value per share
8,643,397
Common Stock, no par value per share
(indirect: Shares directly held by Defiante Farmaceutica L.d.A.)
759,493

DEFIANTE FARMACEUTICA LDA

10% Owner

Transactions

Other
Common Stock, no par value per share
2005-04-15−1,265,822→ 0 total(indirect: Shares underlying the 8% Convertible Debenture held by Defiante Farmaceutica L.d.A.)
Other
8% Convertible Debenture
2005-04-15$2000000.00/sh(indirect: The 8% Convertible Debenture was directly held by Defiante Farmaceutica L.d.A.)
Exercise: $1.58Exp: 2005-04-15→ Common Stock, no par value per share (1,265,822 underlying)

Holdings

Common Stock, no par value per share
(indirect: Shares directly held by Aptafin S.p.A.)
549,100
Common Stock, no par value per share
(indirect: Shares directly held by Defiante Farmaceutica L.d.A.)
759,493
Common Stock, no par value per share
(indirect: Shares directly held by Chaumiere - Consultadoria & Servicos SDC Unipessoal LDA.)
100,000
Common Stock, no par value per share
8,643,397
Common Stock, no par value per share
(indirect: Shares directly held by Claudio Cavazza.)
1,756,781
Common Stock, no par value per share
(indirect: Shares directly held by Paolo Cavazza.)
1,756,782

CAVAZZA PAOLO

10% Owner

Transactions

Other
8% Convertible Debenture
2005-04-15$2000000.00/sh(indirect: The 8% Convertible Debenture was directly held by Defiante Farmaceutica L.d.A.)
Exercise: $1.58Exp: 2005-04-15→ Common Stock, no par value per share (1,265,822 underlying)
Other
Common Stock, no par value per share
2005-04-15−1,265,822→ 0 total(indirect: Shares underlying the 8% Convertible Debenture held by Defiante Farmaceutica L.d.A.)

Holdings

Common Stock, no par value per share
8,643,397
Common Stock, no par value per share
(indirect: Shares directly held by Aptafin S.p.A.)
549,100
Common Stock, no par value per share
(indirect: Shares directly held by Defiante Farmaceutica L.d.A.)
759,493
Common Stock, no par value per share
(indirect: Shares directly held by Claudio Cavazza.)
1,756,781
Common Stock, no par value per share
(indirect: Shares directly held by Paolo Cavazza.)
1,756,782
Common Stock, no par value per share
(indirect: Shares directly held by Chaumiere - Consultadoria & Servicos SDC Unipessoal LDA.)
100,000

Footnotes (4)

[F1]Sigma-Tau Finanziaria S.p.A. owns 100% of the capital stock of Sigma-Tau International S.A. (f/k/a Sigma-Tau Finance Holding S.A.) and 58% of the capital stock of Defiante Farmaceutica L.d.A. Sigma-Tau International S.A. owns 42% of the capital stock of Defiante Farmaceutica L.d.A. Claudio Cavazza owns, directly and indirectly, 60% of Sigma-Tau Finanziaria S.p.A. and Paolo Cavazza owns, directly and indirectly, 40% of Sigma-Tau Finanziaria S.p.A. Paolo Cavazza also owns, directly and indirectly, 100% of Aptafin S.p.A. Aptafin S.p.A. owns, directly and indirectly, 100% of Chaumiere - Consultadoria & Servicos SDC Unipessoal LDA.
[F2]The shares were underlying the 8% Convertible Debenture held by Defiante Farmaceutica L.d.A., which matured on April 15, 2005.
[F3]The 8% Convertible Debenture held by Defiante Farmaceutica L.d.A. was convertible into Common Stock, no par value per share, at any time prior to the maturity date of April 15, 2005.
[F4]The 8% Convertible Debenture matured on April 15, 2005. Questcor Pharmaceuticals Inc. has advised Defiante Farmaceutica L.d.A. that the debenture will be repaid in full.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

QUESTCOR PHARMACEUTICALS INC

CIK 0000891288

→

Entity typeoperating

IncorporatedCA

Related Parties

filerCIK 0000891288

Filing Metadata

Form type: 4
Filed: Apr 18, 8:00 PM ET
Accepted: Apr 19, 5:58 PM ET
Size: 21.3 KB

View on SEC.gov